UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): February 24, 2017

 

PROLOGIS, INC.

PROLOGIS, L.P.

(Exact name of registrant as specified in charter)

 

 

Maryland (Prologis, Inc.)

Delaware (Prologis, L.P.)

 

001-13545 (Prologis, Inc.)

001-14245 (Prologis, L.P.)

 

94-3281941 (Prologis, Inc.)

94-3285362 (Prologis, L.P.)

(State or other jurisdiction

of Incorporation)

 

(Commission

File Number)

 

(I.R.S. Employer

IdentificationNo.)

 

Pier 1, Bay 1, San Francisco, California

 

94111

(Address of Principal Executive Offices)

 

(Zip Code)

Registrants’ Telephone Number, including Area Code: (415) 394-9000

N/A

(Former name or former address, if changed since last report.)

 

Check the appropriate box below if the Form 8K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240 13e-4(c))

 

 

 


ITEM 7.01 Regulation FD Disclosure.

 

On February 24, 2017, our chief executive officer and chairman of the board, Hamid R. Moghadam, adopted a pre-arranged 10b5-1 plan to exercise his vested stock options and sell the underlying shares received upon exercise of such options.  

Mr. Moghadam is adopting such plan to exercise options that have an expiration date in 2021.  This 10b5-1 plan was adopted in accordance with guidelines specified under Rule 10b5-1 of the Securities Exchange Act of 1934, as amended, and our policies regarding stock transactions.  

Options to purchase up to 356,957 shares of our common stock may be exercised under Mr. Moghadam’s 10b5-1 plan. All transactions under his 10b5-1 plan will be disclosed publicly in filings with the U.S. Securities and Exchange Commission.  


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrants have duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

PROLOGIS, INC.

 

 

 

 

Date: February 27, 2017

By:

 

/s/ Deborah K. Briones

 

Name:

 

Deborah K. Briones

 

Title:

 

SVP, Associate General Counsel

 

 

PROLOGIS, L.P.

By: Prologis, Inc.,

its General Partner

 

 

 

 

Date: February 27, 2017

By:

 

/s/ Deborah K. Briones

 

Name:

 

Deborah K. Briones

 

Title:

 

SVP, Associate General Counsel